Report error Found 2763 Enz. Inhib. hit(s) with Target = 'Envelope glycoprotein gp160'
Affinity DataIC50: 0.260nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 0.280nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 0.300nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 0.320nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 0.340nMAssay Description:Inhibition of HIV-1 HXB2 gp41 N-terminal heptad repeat-mediated fusion between infected HL2/3 cells to target TZM-bl cells after 6 hrs by luciferase ...More data for this Ligand-Target Pair
Affinity DataIC50: 0.350nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 0.350nMAssay Description:Inhibition of HIV-1 HXB2 gp41 N-terminal heptad repeat-mediated fusion between infected HL2/3 cells to target TZM-bl cells after 6 hrs by luciferase ...More data for this Ligand-Target Pair
Affinity DataIC50: 0.440nMAssay Description:Inhibition of HIV-1 HXB2 gp41 N-terminal heptad repeat-mediated fusion between infected HL2/3 cells to target TZM-bl cells after 6 hrs by luciferase ...More data for this Ligand-Target Pair
Affinity DataEC50: 0.5nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
Affinity DataEC50: 0.5nMAssay Description:Antiviral HIV activity and compound-induced cytotoxicity were measured in parallel by means of a propidium iodide based procedure in the human T-cell...More data for this Ligand-Target Pair
Affinity DataEC50: 0.5nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
Affinity DataIC50: 0.5nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 0.520nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 0.560nMAssay Description:Inhibition of HIV1 HXB2 gp120-mediated viral infusion into HEK293 cells after 24 hrs by luciferase reporter gene assayMore data for this Ligand-Target Pair
Affinity DataEC50: 0.600nMAssay Description:Antiviral HIV activity and compound-induced cytotoxicity were measured in parallel by means of a propidium iodide based procedure in the human T-cell...More data for this Ligand-Target Pair
Affinity DataEC50: 0.600nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160 [V370A](Human immunodeficiency virus type 1)
Glaxosmithkline
US Patent
Glaxosmithkline
US Patent
Affinity DataEC50: 0.700nMAssay Description:Antiviral HIV activity and compound-induced cytotoxicity were measured in parallel by means of a propidium iodide based procedure in the human T-cell...More data for this Ligand-Target Pair
Affinity DataEC50: 0.700nMAssay Description:Antiviral HIV activity and compound-induced cytotoxicity were measured in parallel by means of a propidium iodide based procedure in the human T-cell...More data for this Ligand-Target Pair
Affinity DataEC50: 0.710nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
Affinity DataEC50: 0.800nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
Affinity DataEC50: 0.800nMAssay Description:Antiviral HIV activity and compound-induced cytotoxicity were measured in parallel by means of a propidium iodide based procedure in the human T-cell...More data for this Ligand-Target Pair
Affinity DataEC50: 0.800nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
Affinity DataEC50: 0.800nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
Affinity DataKd: 0.830nMAssay Description:Inhibition of [3H]BMS-488043 binding to HIV-1 JRFL gp120 after 1 hr by scintillation counting methodMore data for this Ligand-Target Pair
Affinity DataIC50: 0.840nMAssay Description:Inhibition of HIV-1 HXB2 gp41 N-terminal heptad repeat-mediated fusion between infected HL2/3 cells to target TZM-bl cells after 6 hrs by luciferase ...More data for this Ligand-Target Pair
Affinity DataEC50: 0.850nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
Affinity DataIC50: 0.860nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 0.860nMAssay Description:Inhibition of HIV-1 HXB2 gp41 N-terminal heptad repeat-mediated fusion between infected HL2/3 cells to target TZM-bl cells after 6 hrs by luciferase ...More data for this Ligand-Target Pair
Affinity DataEC50: 0.900nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
Affinity DataEC50: 0.900nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160 [V370A](Human immunodeficiency virus type 1)
Glaxosmithkline
US Patent
Glaxosmithkline
US Patent
Affinity DataEC50: 0.900nMAssay Description:Antiviral HIV activity and compound-induced cytotoxicity were measured in parallel by means of a propidium iodide based procedure in the human T-cell...More data for this Ligand-Target Pair
Affinity DataEC50: 0.910nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
Affinity DataEC50: 0.980nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
Affinity DataEC50: 1nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
Affinity DataEC50: 1nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
Affinity DataEC50: 1nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
Affinity DataEC50: 1nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
Affinity DataEC50: 1nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
Affinity DataEC50: 1nMAssay Description:Antiviral HIV activity and compound-induced cytotoxicity were measured in parallel by means of a propidium iodide based procedure in the human T-cell...More data for this Ligand-Target Pair
Affinity DataEC50: 1nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
Affinity DataEC50: 1nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
Affinity DataEC50: 1nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160 [V370A](Human immunodeficiency virus type 1)
Glaxosmithkline
US Patent
Glaxosmithkline
US Patent
Affinity DataEC50: 1nMAssay Description:Antiviral HIV activity and compound-induced cytotoxicity were measured in parallel by means of a propidium iodide based procedure in the human T-cell...More data for this Ligand-Target Pair
Affinity DataEC50: 1nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
Affinity DataEC50: 1nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
Affinity DataEC50: 1nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
Affinity DataEC50: 1.10nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
Affinity DataEC50: 1.10nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
Affinity DataEC50: 1.10nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
Affinity DataIC50: 1.10nMAssay Description:Displacement of soluble CD4 from HIV1 SF162 gp120 after overnight incubation by ELISAMore data for this Ligand-Target Pair
